Correlation between soluble IL-2 receptor serum levels and regulatory T lymphocytes in patients with solid tumors

International Journal of Biological Markers

Volumn 23, Issue 2, 2008, Pages 121-122

  Brivio, F ^a   Lissoni, Paolo ^a   Fumagalli, L ^a   Rovelli, F ^a   Brivio, R ^a   Vigore L ^a   Messina, G ^a   Tisi, E ^a  

^a SAN GERARDO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2 RECEPTOR ALPHA; SOLUBLE INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; BREAST CANCER; CANCER IMMUNOLOGY; CANCER SURGERY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL; LETTER; LUNG NON SMALL CELL CANCER; LYMPHOCYTE COUNT; MACROPHAGE; MALE; METASTASIS; METASTASIS POTENTIAL; MONOCYTE; PROTEIN BLOOD LEVEL; REGULATORY T LYMPHOCYTE; SOLID TUMOR; T LYMPHOCYTE;

EID: 52249119160     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.3729     Document Type: Letter

References (5)

1. Wagner DK, Kiwanuka J, Edwards BK, et al. Soluble interleukin-2 receptor levels in patients with undifferentiated and lymphoblastic lymphomas: correlation to survival. J Clin Oncol 1987; 5: 1262-6.
2. Lissoni P, Bami S, Rescaldani R, Rovelli F, Tancini G. Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours. Br J Cancer 1989; 60: 616-7.
3. Rubin LA, Jay G, Nelson DL. The released interleukin-2 receptor binds interleukin-2 efficiently. J Immunol 1986; 137: 3841-4.
4. Lissoni P, Pittalis S, Brivio F, et al. In vitro modulatory effects of interleukin 3 on macrophage activation induced by interleukin-2. Cancer 1993; 71: 2076-81.
5. Knutson KL, Disis M, Salazar L. CD4 regulatory T cells in human cancer pathogenesis. Cancer Immunol Immunother 2007; 556: 271-85.